TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10100332

Group type: EXPERIMENTAL
Intervention: 20% spacing condition with single-trial KR
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% spacing condition with single-trial KR
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20% spacing condition with summary KR
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20% spacing condition with average KR
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% spacing condition with summary KR
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100% spacing condition with average KR
Number of subjects: 10
Study: 8652333

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg on the evening before and 40 mg on the morning of surgery
Number of subjects: 222

Group type: COMPARATOR
Intervention: Ranitidine 150 mg on the evening before surgery and 2 h before anaesthesia
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg on the morning of surgery
Number of subjects: 222
Study: 1853694

Group type: EXPERIMENTAL
Intervention: Thiopentone (5 mg/kg)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Propofol (2.5 mg/kg)
Number of subjects: 106
Study: 6879233

Group type: EXPERIMENTAL
Intervention: Postcard reminder with expert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postcard reminder with nonexpert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone call reminder with expert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone call reminder with nonexpert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct person‐to‐person reminder with expert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct person‐to‐person reminder with nonexpert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Take‐home card reminder with expert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Take‐home card reminder with nonexpert authority
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal commitment with enhanced importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal commitment with standard importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal plus written commitment with enhanced importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal plus written commitment with standard importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No commitment with enhanced importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No commitment with standard importance message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Take‐home card reminder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No reminder card
Number of subjects: 0
Study: 28982956

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT) followed by medical therapy
Number of subjects: 718

Group type: COMPARATOR
Intervention: Topical medication without laser
Number of subjects: 718
Study: 27832040

Group type: EXPERIMENTAL
Intervention: sitagliptin
Number of subjects: 72

Group type: COMPARATOR
Intervention: diet and exercise
Number of subjects: 72
Study: 26271155

Group type: EXPERIMENTAL
Intervention: GC + bevacizumab
Number of subjects: 353

Group type: COMPARATOR
Intervention: GC + PL
Number of subjects: 353
Study: 23359390

Group type: EXPERIMENTAL
Intervention: Resolute stents
Number of subjects: 382

Group type: COMPARATOR
Intervention: Xience V stents
Number of subjects: 382
Study: 20538115

Group type: EXPERIMENTAL
Intervention: Primary Percutaneous Coronary Intervention (PPCI) in real-world patients
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Primary Percutaneous Coronary Intervention (PPCI) in DANAMI-2 trial patients
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Adjusted hazard ratio for real-world patients vs. DANAMI-2 patients after 1 year
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Adjusted hazard ratio for real-world patients vs. DANAMI-2 patients after 2 years
Number of subjects: 1320
Study: 18181978

Group type: EXPERIMENTAL
Intervention: Desloratadine 5 mg daily for 42 days
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 16611492

Group type: EXPERIMENTAL
Intervention: Retrospective recall of ADHD symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adult reports of lifetime ADHD symptoms
Number of subjects: 0
Study: 12791570

Group type: EXPERIMENTAL
Intervention: 30 mg of the NMDA receptor antagonist memantine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10818175

Group type: EXPERIMENTAL
Intervention: Tetralogy of Fallot patients
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (33 aged-matched asymptomatic subjects)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 8683961

Group type: EXPERIMENTAL
Intervention: Placebo in heavy social drinkers (HSDs)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lorazepam in heavy social drinkers (HSDs)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Lorazepam in light social drinkers (LSDs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo in light social drinkers (LSDs)
Number of subjects: 28
Study: 1641288

Group type: EXPERIMENTAL
Intervention: Hospital discharge package containing a manual breast pump
Number of subjects: 146

Group type: COMPARATOR
Intervention: Commercially available infant formula package
Number of subjects: 146
Study: 6347380

Group type: EXPERIMENTAL
Intervention: Netilmicin, 2 mg/kg every eight hours for a minimum of 72 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tobramycin, 1 mg/kg every eight hours for a minimum of 72 hours
Number of subjects: 30
Study: 29522138

Group type: EXPERIMENTAL
Intervention: Pacritinib (400 mg once daily)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Pacritinib (200 mg twice daily)
Number of subjects: 311

Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 311
Study: 26858332

Group type: EXPERIMENTAL
Intervention: Erlotinib with esomeprazole and cola
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Erlotinib without esomeprazole and cola
Number of subjects: 28
Study: 23799773

Group type: EXPERIMENTAL
Intervention: CISD
Number of subjects: 67

Group type: COMPARATOR
Intervention: Screening
Number of subjects: 67

Group type: COMPARATOR
Intervention: Education
Number of subjects: 67
Study: 22816213

Group type: EXPERIMENTAL
Intervention: L2-3 spinal anesthesia with 15 mg 0.5% isobaric bupivacaine
Number of subjects: 72

Group type: COMPARATOR
Intervention: L3-4 spinal anesthesia with 15 mg 0.5% isobaric bupivacaine
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: L2-3 spinal anesthesia
Number of subjects: 72

Group type: COMPARATOR
Intervention: L3-4 spinal anesthesia
Number of subjects: 72
Study: 20405785

Group type: EXPERIMENTAL
Intervention: EMG amplitude versus dynamic torque relationships for vastus lateralis (VL)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EMG amplitude versus dynamic torque relationships for rectus femoris (RF)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EMG amplitude versus dynamic torque relationships for vastus medialis (VM)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficients for EMG amplitude versus torque coefficients
Number of subjects: 20
Study: 18753098

Group type: EXPERIMENTAL
Intervention: Strict bed rest
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal activity
Number of subjects: 10
Study: 15886747

Group type: EXPERIMENTAL
Intervention: Quantitative bone scan of the sacroiliac joints (lambda parameter)
Number of subjects: 133
Study: 12381637

Group type: EXPERIMENTAL
Intervention: 5 mg/day amiloride (one month)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10507091

Group type: EXPERIMENTAL
Intervention: Special pillow (Curavario, Pala-Medic-Company)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Rehabilitative treatment (physical therapy including gymnastics, electrotherapy, thermotherapy, and massage)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control group (no special pillow)
Number of subjects: 149
Study: 7760967

Group type: EXPERIMENTAL
Intervention: T3 therapy (75-100 micrograms T3 daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Hypothyroid phase
Number of subjects: 14

Group type: COMPARATOR
Intervention: Euthyroid control subjects
Number of subjects: 14
Study: 2180493

Group type: EXPERIMENTAL
Intervention: Chlorambucil (0.1 mg/kg/d)
Number of subjects: 291

Group type: COMPARATOR
Intervention: COP regimen (vincristine, cyclophosphamide, and prednisone)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Chlorambucil
Number of subjects: 291

Group type: COMPARATOR
Intervention: COP
Number of subjects: 291
Study: 7005121

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30776324

Group type: EXPERIMENTAL
Intervention: SMART (n=21)
Number of subjects: 50

Group type: COMPARATOR
Intervention: NDSP (n=19)
Number of subjects: 50
Study: 31648460

Group type: EXPERIMENTAL
Intervention: EXCEL2 stent
Number of subjects: 419
Study: 28711643

Group type: EXPERIMENTAL
Intervention: Condom availability at work
Number of subjects: 946

Group type: EXPERIMENTAL
Intervention: Incarceration
Number of subjects: 946
Study: 25325454

Group type: EXPERIMENTAL
Intervention: 17β estradiol 0.5 mg/day
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: venlafaxine XR 75 mg/day
Number of subjects: 339

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 339
Study: 23271384

Group type: EXPERIMENTAL
Intervention: GLT < 90 mg/dL
Number of subjects: 436

Group type: COMPARATOR
Intervention: GLT 90 to 119 mg/dL
Number of subjects: 436
Study: 21542914

Group type: EXPERIMENTAL
Intervention: Hip school (group A) - 6 weeks, 5 sessions taught by a physiotherapist
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hip school + Manual therapy (group B) - 6 weeks, 5 sessions of hip school + manual therapy twice a week
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal control intervention (group C) - self-care information leaflet with advice on 'live as usual' and stretching exercises from the hip school
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hip school (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hip school + Manual therapy (group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal control intervention (group C)
Number of subjects: 0
Study: 19070834

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) over DLPFC
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS) over DLPFC
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham theta burst stimulation (shamTBS)
Number of subjects: 24
Study: 17562955

Group type: EXPERIMENTAL
Intervention: 81 mg aspirin
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 162 mg aspirin
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 325 mg aspirin
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: All doses of aspirin
Number of subjects: 125
Study: 15380908

Group type: EXPERIMENTAL
Intervention: High-caloric diet (130-150% of the caloric recommendation for age and sex) for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal caloric requirement for 8 weeks
Number of subjects: 30
Study: 11475709

Group type: EXPERIMENTAL
Intervention: Philips/Jordan electric toothbrush with Controlled Pressure system (CPS)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Philips/Jordan electric toothbrush with CPS set at various levels (150-420 g)
Number of subjects: 63
Study: 9789533

Group type: EXPERIMENTAL
Intervention: Standard Fresh Frozen Plasma (FFP)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Solvent/Detergent Treated Pooled Fresh Frozen Plasma (SDFFP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (FFP)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SDFFP
Number of subjects: 28
Study: 8560161

Group type: EXPERIMENTAL
Intervention: Intranasal immunotherapy with Dermatophagoides extract
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2196627

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI) up to 300 mg daily for up to 10 weeks
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519
Study: 362991

Group type: EXPERIMENTAL
Intervention: beclomethasone dipropionate aerosol (BDA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 30798451

Group type: EXPERIMENTAL
Intervention: Educational Lyric Analysis (ELA)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Educational Songwriting (ESW)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control
Number of subjects: 69
Study: 28220020

Group type: EXPERIMENTAL
Intervention: RAM + CAP (10 mg/kg IV, days 1 and 8; 1,000 mg/m2 orally twice daily, days 1-14)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: ICR + CAP (12 mg/kg IV, days 1 and 8; 1,000 mg/m2 orally twice daily, days 1-14)
Number of subjects: 153

Group type: COMPARATOR
Intervention: CAP (1,000 mg/m2 orally twice daily, days 1-14)
Number of subjects: 153
Study: 25267266

Group type: EXPERIMENTAL
Intervention: Laterally wedged insole
Number of subjects: 80

Group type: COMPARATOR
Intervention: Valgus brace
Number of subjects: 80
Study: 24099494

Group type: EXPERIMENTAL
Intervention: Diagnosis threat group
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study: 21692289

Group type: EXPERIMENTAL
Intervention: Needle retaining group
Number of subjects: 26

Group type: COMPARATOR
Intervention: Quick needling group
Number of subjects: 26
Study: 19700033

Group type: EXPERIMENTAL
Intervention: Yogurt-based formula (diet 1)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula (diet 4)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Soy-based formula (diet 2)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Casein-based formula (diet 3)
Number of subjects: 154
Study: 17122169

Group type: EXPERIMENTAL
Intervention: New toothbrush
Number of subjects: 101

Group type: COMPARATOR
Intervention: Old toothbrush
Number of subjects: 101
Study: 12970273

Group type: EXPERIMENTAL
Intervention: Metformin (500 mg, three times daily)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Dianette (ethinyl estradiol, 35 micro g; cyproterone acetate, 2 mg)
Number of subjects: 52
Study: 10562262

Group type: EXPERIMENTAL
Intervention: ST-segment elevation patients
Number of subjects: 12084

Group type: COMPARATOR
Intervention: Non-ST-segment elevation patients
Number of subjects: 12084
Study: 8909666

Group type: EXPERIMENTAL
Intervention: H1 receptor blocker (terfenadine 60 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: H2 receptor blocker (ranitidine 300 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: H1 and H2 receptor blockers (terfenadine 60 mg and ranitidine 300 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no histamine receptor blocker)
Number of subjects: 40
Study: 2072144

Group type: EXPERIMENTAL
Intervention: DTIC plus IFN alfa‐2b
Number of subjects: 64

Group type: COMPARATOR
Intervention: DTIC
Number of subjects: 64
Study: 6222473

Group type: EXPERIMENTAL
Intervention: 5 g mezlocillin given during induction of anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 3990155

Group type: EXPERIMENTAL
Intervention: Phenobarbitone treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no phenobarbitone)
Number of subjects: 52
Study: 28404766

Group type: EXPERIMENTAL
Intervention: Single-session, sexual partner selection and risk decision intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-session, Centers for Disease Control and Prevention-based, sexual risk reduction intervention
Number of subjects: 0
Study: 27381895

Group type: EXPERIMENTAL
Intervention: Primary prostate radiation (68.4Gy)
Number of subjects: 475

Group type: COMPARATOR
Intervention: Postprostatectomy radiation (64.8Gy)
Number of subjects: 475
Study: 24405796

Group type: EXPERIMENTAL
Intervention: 1% lidocaine intracervical injection
Number of subjects: 74

Group type: COMPARATOR
Intervention: Topical application of 2% lidocaine gel
Number of subjects: 74
Study: 22863639

Group type: EXPERIMENTAL
Intervention: Topical olive oil (1 cc, twice a day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no cream or oil)
Number of subjects: 100
Study: 20416525

Group type: EXPERIMENTAL
Intervention: SafeSiders
Number of subjects: 75

Group type: COMPARATOR
Intervention: K-Files
Number of subjects: 75

Group type: COMPARATOR
Intervention: K-Reamers
Number of subjects: 75
Study: 18279418

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 2435
Study: 15914938

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control
Number of subjects: 303
Study: 12881822

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transcutaneous electric nerve stimulation (TENS) therapy
Number of subjects: 60
Study: 10231057

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (3.6 mM)
Number of subjects: 0
Study: 8692532

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: No G-CSF (no cytopenia)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (no G-CSF despite insufficient leukocyte recovery)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 101
Study: 1656181

Group type: EXPERIMENTAL
Intervention: rHu‐EPO treatment (3 X 80 IE/kg/week for six months)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: rHu‐EPO treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 22
Study: 7110806

Group type: EXPERIMENTAL
Intervention: 2.5 mg of fenoterol by nebulizer
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.3 mg of epinephrine followed by 0.75 mg of Sus-Phrine
Number of subjects: 50
Study: 31773688

Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 59
Study: 28637521

Group type: EXPERIMENTAL
Intervention: Guided success at a card-sorting task
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 35
Study: 26829066

Group type: EXPERIMENTAL
Intervention: Egg phospholipids preparation (45 ml, 15 ml 3 times per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Olive oil preparation
Number of subjects: 40
Study: 25129204

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) for 1 year
Number of subjects: 75

Group type: COMPARATOR
Intervention: Cyclosporin A (CsA) for 1 year
Number of subjects: 75
Study: 22347369

Group type: EXPERIMENTAL
Intervention: 60-minute massage group
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual Care control
Number of subjects: 125
Study: 20121986

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention program with a family care coordinator, a geriatrician, support groups for caregivers, and individualized services
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 125
Study: 18217220

Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation programs during inpatient treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-specific ergo-therapeutic treatment (Control)
Number of subjects: 0
Study: 16385703

Group type: EXPERIMENTAL
Intervention: Hand held Doppler (HHD) examination
Number of subjects: 943

Group type: COMPARATOR
Intervention: Duplex imaging
Number of subjects: 943
Study: 12572375

Group type: EXPERIMENTAL
Intervention: Jiannao Yizhi Granule
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 242
Study: 10502218

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 8760776

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate, 50 micrograms
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate, 100 micrograms
Number of subjects: 353

Group type: COMPARATOR
Intervention: Theophylline
Number of subjects: 353

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 353
Study: 1862460

Group type: EXPERIMENTAL
Intervention: Cefotetan plus doxycycline
Number of subjects: 108

Group type: COMPARATOR
Intervention: Cefoxitin plus doxycycline
Number of subjects: 108
Study: 6873140

Group type: EXPERIMENTAL
Intervention: Streptokinase‐streptodornase
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Stabilized crystalline trypsin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both preparations
Number of subjects: 40
Study: 30168416

Group type: EXPERIMENTAL
Intervention: 15-minute IV infusion of levetiracetam
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 45-minute IV infusion of levetiracetam
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral tablets of levetiracetam
Number of subjects: 24
Study: 30346819

Group type: EXPERIMENTAL
Intervention: Telecoaching programme for 24 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual nursing care
Number of subjects: 31
Study: 27490209

Group type: EXPERIMENTAL
Intervention: Green tea polyphenol supplementation (GTPS) for 12 months
Number of subjects: 867

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: Green tea polyphenol supplementation (GTPS) after three months withdrawal
Number of subjects: 867
Study: 23772698

Group type: EXPERIMENTAL
Intervention: Nurse-led rheumatology clinic (intervention group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Rheumatologist-led clinic (control group)
Number of subjects: 107
Study: 22575569

Group type: EXPERIMENTAL
Intervention: Propofol (1.0 mg/kg IV initially, then adjusted based on response)
Number of subjects: 80
Study: 19635718

Group type: EXPERIMENTAL
Intervention: Cognitive intervention and exercises
Number of subjects: 124

Group type: COMPARATOR
Intervention: Instrumented transpedicular fusion
Number of subjects: 124
Study: 18309444

Group type: EXPERIMENTAL
Intervention: Creatine (480 ml of Gatorade plus 5 grams of creatine)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Whey protein (480 ml of Gatorade plus 35 grams of whey protein powder)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Whey protein/creatine (480 ml of Gatorade plus 5 grams of creatine and 35 grams of whey protein powder)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (480 ml of Gatorade)
Number of subjects: 42